1.13.11.4	A112D	the mutant gains the ability to oxidize salicylate and several other monohydroxylated substrates	-, 743728	
1.13.11.4	A112G	mutation does not alter the nature of the Fe-substrate-O2 ternary complex	765091	
1.13.11.4	A112G	the mutant gains the ability to oxidize salicylate and several other monohydroxylated substrates	-, 743728	
1.13.11.4	A112I	the mutant gains the ability to oxidize salicylate and several other monohydroxylated substrates	-, 743728	
1.13.11.4	A112S	the mutant gains the ability to oxidize salicylate and several other monohydroxylated substrates	-, 743728	
1.13.11.4	D120K	complete loss of activity	-, 674253	
1.13.11.4	D175N	inactive mutant enzyme	689914	
1.13.11.4	D225N	activity is comparable to wild-type activity	689914	
1.13.11.4	E223A	102% relative activity compared to the wild type enzyme	674253	
1.13.11.4	E47Q	activity is comparable to wild-type activity	689914